Holdings of Invesco V.I. Health Care Fund
AIM Variable Insurance Funds (Invesco Variable Insurance Funds) · Original filing · Compare with another fund · Report an error
- Net assets
- 160.6M $ including 156.7M $ in equities, 97.6 %
- Positions
- 77 in 7 countries
- Top ten
- 46.7 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 14,514 | 17.4M $ | 10.84 % |
| 2 | Johnson & Johnson | 39,684 | 10.1M $ | 6.27 % |
| 3 | UnitedHealth Group Inc | 23,507 | 9.8M $ | 6.08 % |
| 4 | Merck & Co Inc | 52,450 | 6.7M $ | 4.20 % |
| 5 | Argenx SE | 6,892 | 6.4M $ | 3.98 % |
| 6 | AbbVie Inc | 25,391 | 6.4M $ | 3.98 % |
| 7 | Gilead Sciences Inc | 43,847 | 5.5M $ | 3.45 % |
| 8 | AstraZeneca PLC | 24,827 | 4.7M $ | 2.93 % |
| 9 | BRIGHTSPRING HEALTH SERVICES INC | 62,746 | 4.4M $ | 2.72 % |
| 10 | Welltower Inc | 15,671 | 3.6M $ | 2.21 % |
| 11 | CVS Health Corp | 34,035 | 3.5M $ | 2.19 % |
| 12 | Cardinal Health Inc | 14,255 | 3.4M $ | 2.11 % |
| 13 | Vertex Pharmaceuticals Inc | 6,623 | 3.3M $ | 2.05 % |
| 14 | ROYALTY PHARMA PLC | 57,339 | 3.2M $ | 2.00 % |
| 15 | GUARDANT HEALTH INC | 19,834 | 3M $ | 1.85 % |
| 16 | Axsome Therapeutics Inc | 11,411 | 2.8M $ | 1.74 % |
| 17 | Edwards Lifesciences Corp | 28,490 | 2.6M $ | 1.60 % |
| 18 | UCB SA | 7,580 | 2.3M $ | 1.41 % |
| 19 | Bridgebio Pharma Inc | 28,134 | 2.1M $ | 1.30 % |
| 20 | Ligand Pharmaceuticals Inc | 6,427 | 2M $ | 1.26 % |
| 21 | Sandoz Group AG | 22,014 | 2M $ | 1.24 % |
| 22 | Waters Corp | 5,140 | 1.9M $ | 1.20 % |
| 23 | Ascendis Pharma A/S | 7,074 | 1.9M $ | 1.17 % |
| 24 | NATERA INC | 6,812 | 1.8M $ | 1.15 % |
| 25 | REVOLUTION MEDICINES INC | 9,137 | 1.7M $ | 1.07 % |
| 26 | Protagonist Therapeutics Inc | 13,525 | 1.7M $ | 1.03 % |
| 27 | United Therapeutics Corp | 2,998 | 1.6M $ | 1.01 % |
| 28 | Intuitive Surgical Inc | 3,973 | 1.6M $ | 0.98 % |
| 29 | Halozyme Therapeutics Inc | 20,180 | 1.6M $ | 0.98 % |
| 30 | IQVIA Holdings Inc | 7,880 | 1.5M $ | 0.95 % |
| 31 | Madrigal Pharmaceuticals Inc | 2,753 | 1.5M $ | 0.92 % |
| 32 | Galderma Group AG | 6,470 | 1.5M $ | 0.92 % |
| 33 | Medline Inc | 34,369 | 1.4M $ | 0.84 % |
| 34 | West Pharmaceutical Services Inc | 3,646 | 1.3M $ | 0.81 % |
| 35 | Mettler-Toledo International Inc | 1,020 | 1.3M $ | 0.81 % |
| 36 | Lonza Group AG | 1,915 | 1.3M $ | 0.80 % |
| 37 | Quest Diagnostics Inc | 5,645 | 1.2M $ | 0.74 % |
| 38 | ALIGNMENT HEALTHCARE INC | 49,963 | 1.2M $ | 0.74 % |
| 39 | Charles River Laboratories International Inc | 5,131 | 1.2M $ | 0.72 % |
| 40 | Thermo Fisher Scientific Inc | 2,283 | 1.1M $ | 0.71 % |
| 41 | IONIS PHARMACEUTICALS INC | 13,962 | 1.1M $ | 0.69 % |
| 42 | IDEXX Laboratories Inc | 2,078 | 1.1M $ | 0.68 % |
| 43 | Insmed Inc | 9,751 | 1M $ | 0.65 % |
| 44 | TWIST BIOSCIENCE CORP | 9,702 | 998.1K $ | 0.62 % |
| 45 | Labcorp Holdings Inc | 3,544 | 992.3K $ | 0.62 % |
| 46 | CYTOKINETICS INC | 11,172 | 951.7K $ | 0.59 % |
| 47 | STERIS PLC | 4,309 | 907.3K $ | 0.56 % |
| 48 | Globus Medical Inc | 11,395 | 900.3K $ | 0.56 % |
| 49 | Repligen Corp | 6,148 | 838.8K $ | 0.52 % |
| 50 | Rhythm Pharmaceuticals Inc | 7,408 | 822.5K $ | 0.51 % |
| 51 | TENET HEALTHCARE CORP | 4,134 | 773.4K $ | 0.48 % |
| 52 | Krystal Biotech Inc | 1,968 | 731.4K $ | 0.46 % |
| 53 | Praxis Precision Medicines Inc | 2,166 | 725.2K $ | 0.45 % |
| 54 | Encompass Health Corp | 6,970 | 704.5K $ | 0.44 % |
| 55 | HCA Healthcare Inc | 1,777 | 692.8K $ | 0.43 % |
| 56 | MIRUM PHARMACEUTICALS INC | 5,850 | 684.9K $ | 0.43 % |
| 57 | Arrowhead Pharmaceuticals Inc | 7,737 | 630.6K $ | 0.39 % |
| 58 | Regeneron Pharmaceuticals Inc | 1,002 | 624.8K $ | 0.39 % |
| 59 | Medpace Holdings Inc | 1,130 | 598.4K $ | 0.37 % |
| 60 | Rapport Therapeutics Inc | 14,308 | 596.2K $ | 0.37 % |
| 61 | McKesson Corp | 785 | 593.1K $ | 0.37 % |
| 62 | BioLife Solutions Inc | 19,732 | 557.2K $ | 0.35 % |
| 63 | LeMaitre Vascular Inc | 5,730 | 549.9K $ | 0.34 % |
| 64 | Billiontoone Inc | 4,385 | 526.1K $ | 0.33 % |
| 65 | RadNet Inc | 7,870 | 485.3K $ | 0.30 % |
| 66 | HeartFlow Inc | 15,766 | 462.6K $ | 0.29 % |
| 67 | Dianthus Therapeutics Inc | 4,361 | 425.1K $ | 0.26 % |
| 68 | PALVELLA THERAPEUTICS INC | 2,691 | 411.2K $ | 0.26 % |
| 69 | TARSUS PHARMACEUTICALS INC | 6,525 | 410.7K $ | 0.26 % |
| 70 | Xenon Pharmaceuticals Inc | 6,800 | 410.4K $ | 0.26 % |
| 71 | Glaukos Corp | 2,922 | 408.4K $ | 0.25 % |
| 72 | COGENT BIOSCIENCES INC | 9,662 | 373.9K $ | 0.23 % |
| 73 | uniQure NV | 6,887 | 317.2K $ | 0.20 % |
| 74 | Centene Corp | 4,932 | 316.6K $ | 0.20 % |
| 75 | Phathom Pharmaceuticals Inc | 24,059 | 261K $ | 0.16 % |
| 76 | GMR Solutions Inc | 15,649 | 241.9K $ | 0.15 % |
| 77 | Mineralys Therapeutics Inc | 7,305 | 197.1K $ | 0.12 % |
Sector breakdown
- Health care 64.7 %
- Real estate 2.3 %
- Unattributed 33.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 95.5 %
- CHF 3.0 %
- EUR 1.4 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 86.8 %
- Netherlands 4.3 %
- Switzerland 3.0 %
- United Kingdom 3.0 %
- Belgium 1.4 %
- Denmark 1.2 %
- Canada 0.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 68 | 136M $ | 86.77 % |
| 2 | Netherlands | 2 | 6.7M $ | 4.28 % |
| 3 | Switzerland | 3 | 4.8M $ | 3.03 % |
| 4 | United Kingdom | 1 | 4.7M $ | 3.00 % |
| 5 | Belgium | 1 | 2.3M $ | 1.45 % |
| 6 | Denmark | 1 | 1.9M $ | 1.20 % |
| 7 | Canada | 1 | 410.4K $ | 0.26 % |
Cite this page
Titelia. "Holdings of Invesco V.I. Health Care Fund". https://titelia.com/en/funds/S000000193